A Review of Controversial Issues in the Management of Head and Neck Cancer: A Swiss Multidisciplinary and Multi-Institutional Patterns of Care Study—Part 4 (Biomarkers)

Por Martina A. Broglie, Martina A. Broglie, Pavel Dulguerov, Guido Henke, Marco Siano, Marco Siano, Paul Martin Putora, Paul Martin Putora, Christian Simon, Daniel Zwahlen, Daniel Zwahlen, Gerhard F. Huber, Gerhard F. Huber, Giorgio Ballerini, Lorenza Beffa, Roland Giger, Sacha Rothschild, Sandro V. Negri, Olgun Elicin
Publicado em 2019-10-01

Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?

Por Paolo Bossi, Marco Siano, Cristiana Bergamini, Maria Cossu Rocca, Andrea P. Sponghini, Marco Giannoccaro, Luca Tonella, Alessandro Paoli, Edoardo Marchesi, Federica Perrone, Silvana Pilotti, Laura D. Locati, Silvana Canevari, Lisa Licitra, Loris De Cecco
Publicado em 2017-01-01

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Por Mirjam Fässler, Stefan Diem, Joanna Mangana, Omar Hasan Ali, Fiamma Berner, David Bomze, Sandra Ring, Rebekka Niederer, Cristina del Carmen Gil Cruz, Christian Ivan Pérez Shibayama, Michal Krolik, Marco Siano, Markus Joerger, Mike Recher, Lorenz Risch, Sabine Güsewell, Martin Risch, Daniel E. Speiser, Burkhard Ludewig, Mitchell P. Levesque, Reinhard Dummer, Lukas Flatz
Publicado em 2019-02-01